Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 14, 2021 - Issue
Submit an article Journal homepage
129
Views
7
CrossRef citations to date
0
Altmetric
Case Report

Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy

Taoming LiuDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Juan BaiDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Su WangDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Shuni YingDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
,
Sheng LiDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4641-7907
ORCID Icon,
Jianjun QiaoDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-3386-297X
ORCID Icon &
Hong FangDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
 show all
Pages 175-178 | Published online: 04 Mar 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Angelina Labib, Teresa Ju, Ashley Vander Does & Gil Yosipovitch. (2022) Immunotargets and Therapy for Prurigo Nodularis. ImmunoTargets and Therapy 11, pages 11-21.
Read now

Articles from other publishers (6)

Henning Olbrich, Christian D. Sadik, Ralf J. Ludwig, Diamant Thaçi & Katharina Boch. (2023) Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules 13:4, pages 634.
Crossref
Wenwen Jing, Danyang Yang, Xin Liu, Li Li, Tao Lu & Xiaoli Li. (2023) Dupilumab Therapy of Prurigo Nodularis: A Single-Center, Real-Life Observational Study. Dermatologic Therapy 2023, pages 1-8.
Crossref
Peng Cao, Wenjing Xu, Shuyi Jiang & Litao Zhang. (2023) Dupilumab for the treatment of prurigo nodularis: A systematic review. Frontiers in Immunology 14.
Crossref
Shinji Mitsuyama & Tetsuya Higuchi. (2023) Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis. Anais Brasileiros de Dermatologia 98:1, pages 86-89.
Crossref
M. Gael, T. Adam, M. Mariano‐Bourin & A.‐C. Bursztejn. (2022) Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors. Journal of the European Academy of Dermatology and Venereology 36:9, pages 1541-1551.
Crossref
. (2021) Gabapentin/thalidomide. Reactions Weekly 1854:1, pages 162-162.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.